Market Cap (In TWD)
1.13 Billion
Revenue (In TWD)
167.17 Million
Net Income (In TWD)
-58.53 Million
Avg. Volume
37.96 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 10.35-14.9
- PE
- -16.59
- EPS
- -0.66
- Beta Value
- 0.386
- ISIN
- TW0006572001
- CUSIP
- -
- CIK
- -
- Shares
- 103650000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Healthcare
- CEO
- Dr. Dean Tsao Ph.D.
- Employee Count
- -
- Website
- https://www.plexbio.com
- Ipo Date
- 2016-02-26
- Details
- PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers workflow navigation services; automated sample preparation extraction kits; IntelliPlex platform that is designed for pCode technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-CoV-2 detection test kits/flu kits and IntelliPlex SARS-CoV-2 variant analysis kits; and pCode coupling buffer sets. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.
More Stocks
-
BFST
-
MHLXMIRUMahalaxmi Rubtech Limited
MHLXMIRU
-
6939TFBS Bioscience Inc.
6939
-
GAM
-
HRFEFHarfang Exploration Inc.
HRFEF
-
7992
-
WAPO
-
PREIFPrecipitate Gold Corp.
PREIF